WELCOME TO NUCLEIC CAPITAL

Generating alpha at the intersection of biotechnology and software

OUR VISION

At Nucleic Capital, we believe that the next great leap in economic growth will be driven by biological engineering, unleashing a new era in company formation, productivity growth and wealth generation. Through strategic biotechnology and software investments, we target opportunities where technology advancements intersect with healthcare and synthetic biology to make the world a better place.

OUR SERVICES

Investing in Listed Equities Globally

BIOTECH INVESTMENTS

Nucleic Capital specializes in biotechnology and software investments, using deep domain expertise and proprietary, in house analysis to identify opportunities. Our team of experts is dedicated to powering the emerging era of synthetic biology to cure disease, reorder global supply chains and transform society.

FRONTIER OF BIOLOGY

Deep integration of AI, software and hardware is finally transforming the frontier of biology, allowing us to program cells and manufacture in new ways.

SYNTHETIC BIOLOGY

We invest in synthetic biology to create new and innovative solutions to some of the world's most pressing problems. Our team of experts is dedicated to identifying opportunities in this field.

WHY CHOOSE US

Specialist Biotechnology Investment Firm

At Nucleic Capital, we take a different approach to biotechnology investments. We are a specialist investment firm that focuses on creating value for our partners through strategic investments.

CAREERS

At Nucleic Capital, we are always looking for innovative talent to join our team. Submit your CV.

Submit CV

INVESTMENT ANALYST

Channel Islands

We are seeking a molecular biologists with biotech or Pharma industry experience to join our team in Guernsey.

Apply Now